HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arijit Biswas Selected Research

Methyltransferases

8/2021PPAR-Responsive Elements Enriched with Alu Repeats May Contribute to Distinctive PPARγ-DNMT1 Interactions in the Genome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arijit Biswas Research Topics

Disease

16Hemorrhage
10/2023 - 03/2006
12Neoplasms (Cancer)
08/2021 - 01/2007
8Thrombosis (Thrombus)
01/2023 - 02/2005
7Venous Thrombosis (Deep-Vein Thrombosis)
03/2022 - 02/2005
7Stroke (Strokes)
11/2017 - 11/2008
5COVID-19
05/2021 - 01/2020
4Aneuploidy (Aneuploid)
11/2022 - 04/2012
4Lymphoma (Lymphomas)
01/2020 - 08/2014
4Wounds and Injuries (Trauma)
07/2019 - 02/2014
4Ischemic Stroke
01/2019 - 03/2009
3Hemophilia A (Haemophilia)
04/2024 - 03/2006
3Fetofetal Transfusion (Twin Transfusion Syndrome)
01/2022 - 06/2017
3von Willebrand Diseases (von Willebrand's Disease)
01/2021 - 10/2012
3Pre-Eclampsia (Preeclampsia)
01/2019 - 01/2014
2Hemolysis
04/2024 - 01/2021
2Factor XIII Deficiency
10/2023 - 06/2010
2Hydrops Fetalis (Fetal Edema)
01/2023 - 02/2007
2Hyperhomocysteinemia
03/2022 - 03/2006
21 Combined Deficiency Of Vitamin K-Dependent Clotting Factors
01/2022 - 01/2021
2Pregnancy Complications
08/2021 - 11/2018
2Gestational Diabetes (Gestational Diabetes Mellitus)
08/2021 - 01/2015
2Infections
03/2021 - 04/2017
2Keloid
01/2020 - 05/2014
2Vascular Diseases (Vascular Disease)
11/2017 - 09/2014
2Hydatidiform Mole (Molar Pregnancy)
01/2015 - 10/2014
2Carcinogenesis
01/2015 - 02/2012
2Carcinoma (Carcinomatosis)
02/2013 - 06/2012
2Osteosarcoma (Osteogenic Sarcoma)
02/2013 - 06/2012
2Activated Protein C Resistance (APC Resistance)
09/2009 - 06/2008
1Insulin Resistance
05/2024
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2023
1Brain Diseases (Brain Disorder)
01/2023
1Birth Weight (Birth Weights)
08/2021

Drug/Important Bio-Agent (IBA)

11Conditioned Culture MediaIBA
01/2020 - 06/2012
10Proteins (Proteins, Gene)FDA Link
01/2023 - 03/2008
5Factor XIII (Coagulation Factor XIII)IBA
10/2023 - 06/2010
5von Willebrand FactorIBA
01/2021 - 10/2012
5factor V LeidenIBA
02/2017 - 02/2005
4Protein CIBA
01/2021 - 02/2005
3Fibrinogen (Factor I)FDA Link
04/2024 - 01/2017
3HomocysteineIBA
03/2022 - 03/2006
3Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2022 - 05/2010
3Blood Coagulation Factors (Coagulation Factor)IBA
01/2022 - 08/2014
3Vitamin KFDA Link
01/2022 - 08/2014
3AntigensIBA
09/2014 - 11/2008
3Bromodeoxyuridine (BrdU)IBA
08/2014 - 06/2012
3Green Fluorescent ProteinsIBA
04/2014 - 12/2009
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 06/2012
3Factor VIII (Coagulation Factor VIII)IBA
09/2009 - 03/2006
2Insulin (Novolin)FDA Link
05/2024 - 01/2019
2Heme (Haem)IBA
04/2024 - 01/2021
2DNA (Deoxyribonucleic Acid)IBA
08/2021 - 02/2007
2CytokinesIBA
05/2021 - 05/2014
2AnticoagulantsIBA
03/2021 - 01/2018
2Prothrombin (Factor II)IBA
01/2021 - 09/2009
2Hemostatics (Antihemorrhagics)IBA
01/2021 - 05/2009
2AntithrombinsIBA
10/2020 - 01/2008
2VaccinesIBA
01/2020 - 04/2017
2MicroRNAs (MicroRNA)IBA
10/2019 - 12/2017
2CollagenIBA
07/2019 - 04/2014
2Interleukin-6 (Interleukin 6)IBA
01/2019 - 12/2018
2Plasminogen Activator Inhibitor 1IBA
11/2017 - 04/2010
2Plasminogen Activators (Plasminogen Activator)IBA
11/2017 - 04/2010
2Cell-Free Nucleic AcidsIBA
06/2017 - 01/2017
2Biomarkers (Surrogate Marker)IBA
01/2017 - 03/2013
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2016 - 08/2014
2Glutathione PeroxidaseIBA
09/2014 - 08/2014
2Superoxide DismutaseIBA
08/2014 - 04/2014
2involucrinIBA
04/2014 - 02/2014
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
04/2014 - 02/2014
2Tissue Inhibitor of Metalloproteinase-1IBA
04/2014 - 02/2014
2Keratins (Keratin)IBA
04/2014 - 02/2014
2Filaggrin ProteinsIBA
04/2014 - 02/2014
2polyacrylamideIBA
03/2013 - 05/2009
2Antiphospholipid AntibodiesIBA
09/2009 - 04/2005
2Factor V (Coagulation Factor V)IBA
09/2009 - 06/2008
2EnzymesIBA
03/2009 - 01/2007
1LigandsIBA
05/2024
1Hypoglycemic Agents (Hypoglycemics)IBA
05/2024
1AdipokinesIBA
05/2024
1protoporphyrin IXIBA
04/2024
1Messenger RNA (mRNA)IBA
01/2023
1Lipid NanoparticlesIBA
01/2023
1FibrinIBA
01/2023
1DiamondIBA
01/2023
1AdenineFDA LinkGeneric
01/2023
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
03/2022
1Matrix Gla ProteinIBA
01/2022
1PPAR gammaIBA
08/2021
1MethyltransferasesIBA
08/2021
1Glucose (Dextrose)FDA LinkGeneric
08/2021

Therapy/Procedure

10Therapeutics
04/2024 - 04/2005
3Lasers (Laser)
01/2022 - 03/2013
3Cesarean Section (Caesarean Section)
08/2021 - 01/2008
3Transplantation
11/2015 - 02/2012
2Light Coagulation
01/2022 - 06/2017
2Injections
07/2019 - 02/2013
2Fetal Therapies (Fetal Therapy)
06/2017 - 01/2017
1Semiconductors
11/2022
1Artificial Respiration (Mechanical Ventilation)
03/2021